These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 30148543)
1. [CLINICAL RECOMMENDATIONS FOR DIAGNOSIS, TREATMENT AND MONITORING OF PATIENTS WITH ESOPHAGEAL AND ESOPHAGOGASTRIC JUNCTION CANCERS]. Bišof V; Juretić A; Stančić-Rokotov D; Rustemović N; Miletić D; Boban M; Omrčen T; Razumović JJ; Pavlović I; Fröbe A; Čonkaš M; Rakušić Z; Gugić D Lijec Vjesn; 2016; 138(9-10):233-9. PubMed ID: 30148543 [TBL] [Abstract][Full Text] [Related]
2. Individualized surgical strategies for cancer of the esophagogastric junction. Stein HJ; Feith M; Siewert JR Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787 [TBL] [Abstract][Full Text] [Related]
5. Role of repeat staging laparoscopy in locoregionally advanced gastric or gastroesophageal cancer after neoadjuvant therapy. Cardona K; Zhou Q; Gönen M; Shah MA; Strong VE; Brennan MF; Coit DG Ann Surg Oncol; 2013 Feb; 20(2):548-54. PubMed ID: 22941159 [TBL] [Abstract][Full Text] [Related]
6. Management of Locally Advanced Adenocarcinoma of the Esophagus and Gastroesophageal Junction: Finally a Consensus. Kleinberg L; Brock M; Gibson M Curr Treat Options Oncol; 2015 Jul; 16(7):35. PubMed ID: 26112428 [TBL] [Abstract][Full Text] [Related]
7. Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach? Heger U; Blank S; Wiecha C; Langer R; Weichert W; Lordick F; Bruckner T; Dobritz M; Burian M; Springfeld C; Grenacher L; Siewert JR; Büchler M; Ott K Ann Surg Oncol; 2014 May; 21(5):1739-48. PubMed ID: 24419755 [TBL] [Abstract][Full Text] [Related]
8. International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus. Moehler M; Baltin CT; Ebert M; Fischbach W; Gockel I; Grenacher L; Hölscher AH; Lordick F; Malfertheiner P; Messmann H; Meyer HJ; Palmqvist A; Röcken C; Schuhmacher C; Stahl M; Stuschke M; Vieth M; Wittekind C; Wagner D; Mönig SP Gastric Cancer; 2015 Jul; 18(3):550-63. PubMed ID: 25192931 [TBL] [Abstract][Full Text] [Related]
9. [A case of adenocarcinoma of the esophagogastric junction successfully treated with chemoradiation therapy]. Ebisui C; Okada K; Nishigaki T; Owada Y; Nagase H; Mukai R; Momozane T; Murakami M; Ide Y; Yanagisawa T; Murata K; Yokouchi H; Tamai M; Kinuta M Gan To Kagaku Ryoho; 2011 Nov; 38(12):2143-5. PubMed ID: 22202310 [TBL] [Abstract][Full Text] [Related]
10. Is There a Precise Adjuvant Therapy for Esophagogastric Carcinoma? Cartwright E; Keane FK; Enzinger PC; Hong T; Chau I Am Soc Clin Oncol Educ Book; 2018 May; 38():280-291. PubMed ID: 30231360 [TBL] [Abstract][Full Text] [Related]
12. It is time for a proper staging system for adenocarcinoma of the gastroesophageal junction. Pedrazzani C; de Manzoni G; Marrelli D; Roviello F J Clin Oncol; 2007 Mar; 25(7):907-8; author reply 908-9. PubMed ID: 17327616 [No Abstract] [Full Text] [Related]
13. Multidisciplinary approach to esophageal and gastric cancer. Stein HJ; Sendler A; Fink U; Siewert JR Surg Clin North Am; 2000 Apr; 80(2):659-82; discussions 683-6. PubMed ID: 10836011 [TBL] [Abstract][Full Text] [Related]
14. Siewert III Adenocarcinoma: Still Searching for the Right Treatment Combination. Tang A; Sohal D; McNamara M; Murthy SC; Raja S Surg Oncol Clin N Am; 2020 Oct; 29(4):647-653. PubMed ID: 32883464 [TBL] [Abstract][Full Text] [Related]
15. A Case of Alpha-Fetoprotein-Producing Adenocarcinoma of the Esophagogastric Junction in which Long-Term Survival Was Achieved by Means of Individualized Multidisciplinary Therapy. Tanaka K; Fujiya M; Ijiri M; Takahashi K; Ando K; Nomura Y; Ueno N; Kashima S; Goto T; Sasajima J; Ito T; Moriichi K; Mizukami Y; Tanabe H; Okumura T J Gastrointest Cancer; 2019 Sep; 50(3):617-620. PubMed ID: 29457212 [No Abstract] [Full Text] [Related]
16. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group. Van Cutsem E; Van de Velde C; Roth A; Lordick F; Köhne CH; Cascinu S; Aapro M; Eur J Cancer; 2008 Jan; 44(2):182-94. PubMed ID: 18093827 [TBL] [Abstract][Full Text] [Related]
18. Diagnosis and treatment of non-metastatic esophagogastric junction adenocarcinoma: what are the current options? Gronnier C; Piessen G; Mariette C J Visc Surg; 2012 Feb; 149(1):e23-33. PubMed ID: 22341763 [TBL] [Abstract][Full Text] [Related]
19. Management of Locally Advanced Gastroesophageal Cancer: Still a Multidisciplinary Global Challenge? Al-Batran SE; Lorenzen S Hematol Oncol Clin North Am; 2017 Jun; 31(3):441-452. PubMed ID: 28501086 [TBL] [Abstract][Full Text] [Related]
20. The multidisciplinary management of gastro-oesophageal junction tumours: European Society of Digestive Oncology (ESDO): Expert discussion and report from the 16th ESMO World Congress on Gastrointestinal Cancer, Barcelona. Van Laethem JL; Carneiro F; Ducreux M; Messman H; Lordick F; Ilson DH; Allum WH; Haustermans K; Lepage C; Matysiak-Budnik T; Cats A; Schmiegel W; Cervantes A; Van Cutsem E; Rougier P; Seufferlein T Dig Liver Dis; 2016 Nov; 48(11):1283-1289. PubMed ID: 27590840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]